Skip to main content

Market Overview

AbbVie Reports Q4 Earnings Beat

Share:
AbbVie Reports Q4 Earnings Beat

AbbVie (NYSE: ABBV) shares are trading higher on Friday after the company reported better-than-expected fourth-quarter EPS and sales results.

The company reported quarterly earnings of $2.21 per share, which beat the analyst consensus estimate of $2.19. This is a 16.32% increase over earnings of $1.9 per share from the same period last year.

AbbVie reported quarterly sales of $8.704 billion, which beat the analyst consensus estimate of $8.7 billion. This is a 4.8% increase over sales of $8.305 billion in the same period last year.

The Daily Biotech Pulse: Assertio To Sell Opioid Pain Drug, Milestone Payment For Aduro, Myriad Genetics CEO Resigns

The company also issued fiscal year 2020 EPS guidance above analyst estimates and sales. AbbVie sees fiscal year 2020 adjusted EPS $9.61-$9.71 versus the $9.48 estimate and sales growth at ~8%.

AbbVie shares were trading up 3.2% at $90 in Friday’s pre-market session. The stock has a 52-week high of $91.99 and a 52-week low of $62.66.

 

Related Articles (ABBV)

View Comments and Join the Discussion!

Posted-In: Earnings News Best of Benzinga

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com